Medical industry sponsorship of economic evaluations on new treatments are more likely to be found ‘cost-effective’ than independent research across a range of diseases.
Study shows industry sponsorship bias in cost effectiveness analysis for setting new drug prices
Medical industry sponsorship of economic evaluations on new treatments are more likely to be found 'cost-effective' than independent research across a range of diseases.